Stocks and Investing
Stocks and Investing
Wed, October 4, 2023
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
[ Wed, Oct 04th 2023
] - WOPRAI
Michael Leithead Maintained (CC) at Hold with Decreased Target to $31 on, Oct 4th, 2023
Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $40 to $31 on, Oct 4th, 2023.
Michael has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Reiterated at Hold and Held Target at $33 on, Tuesday, August 1st, 2023
- Arun Viswanathan of "RBC Capital" Maintained at Hold with Increased Target to $40 on, Monday, July 31st, 2023
- Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $37 on, Thursday, June 22nd, 2023
These are the ratings of the 2 analyists that currently disagree with Michael
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $53 on, Wednesday, August 2nd, 2023
- Joshua Spector of "UBS" Maintained at Strong Buy with Increased Target to $43 on, Tuesday, June 13th, 2023
Contributing Sources